Mirati’s New CEO Clears Out Execs Ahead Of Key Filing And Readout

Keytruda Combo Data Next Week

 
• By Andrew McConaghie
Mirati
The San Diego-based company is set to file adagrasib with the US regulator by the end of 2021. • Source: Alamy

More from Anticancer

More from Therapy Areas